麗珠醫藥(01513.HK)擬使用不超4億元閒置募集資金進行現金管理
格隆匯6月4日丨麗珠醫藥(01513.HK)公佈,於2020年5月29日,公司董事會會議審議通過《關於提名公司第十屆董事會非獨立董事的議案》,鑑於公司第九屆董事會任期將於2020年6月29日屆滿,經與會董事認真審議,一致同意提名朱保國先生、陶德勝先生、邱慶豐先生、俞雄先生為公司第十屆董事會非執行董事候選人,提名唐陽剛先生、徐國祥先生為公司第十屆董事會執行董事候選人。
審議通過《關於提名公司第十屆董事會獨立董事的議案》,鑑於公司第九屆董事會任期將於2020年6月29日屆滿,經與會董事認真審議,一致同意提名白華先生、鄭志華先生、謝耘先生、田秋生先生、黃錦華先生為公司第十屆董事會獨立非執行董事候選人。
審議通過《關於開展外匯衍生品交易業務的議案》,經與會董事認真審議,同意公司及下屬附屬公司根據實際發展的需要,開展遠期外匯衍生品交易業務,主要包括遠期結售匯及相關組合業務,交易金額不超過14億元人民幣,上述交易業務自交易日至到期日期限不超過一年。
此外,審議通過《關於使用閒置募集資金進行現金管理的議案》,為提高公司募集資金使用效率、增加股東回報,同意公司在確保不影響募集資金項目實施以及募集資金使用的情況下,使用不超過人民幣40,000萬元閒置募集資金進行現金管理,購買安全性高、流動性好的保本型理財產品或高收益的存款產品。閒置募集資金進行現金管理的使用期限為自本次董事會審議通過之日起12個月內,在上述額度內,資金可以滾動使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.